Flentje A
ORCID: 0000-0002-1964-4151
· 6 papers in corpus
qualitative
2026
Many transmasculine and gender diverse people assigned female at birth people use testosterone as gender-affirming hormone therapy, which is associated with significant changes to sexual and reproductive health. Additionally, transmasculine…
observational
2026
Gender minority (GM) persons have been reported to experience chronic pain at higher rates than the general population, yet comprehensive pain phenotyping in this group remains underexplored. The goal of this cross-sectional study was to ch…
observational
2025
BACKGROUND: There are limited data on pelvic pain among transgender men and gender diverse people, and the impact of testosterone on pelvic pain is poorly understood. OBJECTIVE: Characterize the prevalence and correlates of chronic pelvic …
other
2025
OBJECTIVES: To describe contraceptive use for pregnancy prevention among transgender men and gender diverse (TGD) individuals assigned female or intersex at birth (AFIAB) and explore whether contraceptive use differs by testosterone use. S…
observational
2025
ObjectivesTo explore whether discussing contraceptive use with a healthcare provider is associated with current contraceptive use among transgender men and gender-diverse (TMGD) individuals.Study designIn 2019, we conducted a cross-sectiona…
observational
2023
BACKGROUND: Testosterone use among transgender people likely impacts their experience of sexual function and vulvovaginal pain via several complex pathways. Testosterone use is associated with decreased estrogen in the vagina and atrophic v…